Insider trading · Q3 2026 · CIK 873303

Sarepta Therapeutics, Inc. (SRPT) insider trading.

In Q3 2026, insiders at Sarepta Therapeutics, Inc. reported 5 non-derivative transactions on 6 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.

Transactions
5
Purchases (P)
0
Sales (S)
0
Net shares, P minus S
0
Insiders
5
Last filed
2026-09-08

Insiders

InsiderRelationshipTransactionsBuysSales
Rodino-Klapac LouiseOfficer · President, R&D and Tech Ops100
Rothfuss CristinOfficer · EVP, General Counsel100
Estepan Ian MichaelOfficer · Chief Operating Officer100
Wong Ryan Ho-YanOfficer · Chief Financial Officer100
Severino MichaelDirector, Officer · Chief Executive Officer100

Transactions

5 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-04Rodino-Klapac LouiseF (D)21,423$22.22203,900Form 4
2026-09-04Rothfuss CristinF (D)22,025$22.22115,519Form 4
2026-09-04Estepan Ian MichaelF (D)24,799$22.22177,184Form 4
2026-09-04Wong Ryan Ho-YanF (D)13,272$22.22121,792Form 4
2026-07-28Severino MichaelA (A)756,104—756,104Form 4

Transaction codes in this quarter

Get SRPT insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=873303&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · SRPT company page · Sarepta Therapeutics, Inc. on SEC.gov

Questions

Are insiders buying or selling Sarepta Therapeutics, Inc. (SRPT)?

In Q3 2026, insiders at Sarepta Therapeutics, Inc. reported 5 non-derivative transactions on 6 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Sarepta Therapeutics, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/srpt.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.